Hepatitis C virus distribution and clearance following interferon-monotherapy among thalassaemia major and intermedia patients

British Journal of Haematology

Volumn 155, Issue 4, 2011, Pages 524-527

  Ricchi, Paolo ^a   Lanza, Alfonso G ^b   Ammirabile, Massimiliano ^a   Costantini, Silvia ^a   Cinque, Patrizia ^a   Spasiano, Anna ^a   Di Matola, Tiziana ^c   Di Costanzo, Giovan G ^b   Pagano, Leonilde ^a   Prossomariti, Luciano ^a  

^a CARDARELLI HOSPITAL   (Italy)

^b AORN A Cardarelli   (Italy)

^c AO Dei Colli Hospital for Infectious Diseases D Cotugno   (Italy)

Author keywords

Haemolytic anaemia; Hepatitis; Interferon; Iron overload; Thalassaemia

Indexed keywords

ALANINE AMINOTRANSFERASE; DEFERIPRONE; PEGINTERFERON; RECOMBINANT ALPHA2 INTERFERON; RECOMBINANT ALPHA2A INTERFERON; STEROID; VIRUS RNA;

ADULT; AGRANULOCYTOSIS; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNE HEMOLYTIC ANEMIA; COMORBIDITY; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LEISHMANIASIS; LETTER; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NEUTROPENIA; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; THALASSEMIA; THALASSEMIA INTERMEDIA; THALASSEMIA MAJOR; THROMBOCYTOPENIA; TREATMENT RESPONSE; VIRAL CLEARANCE;

ADULT; ANTIVIRAL AGENTS; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; MALE; POLYETHYLENE GLYCOLS; RECOMBINANT PROTEINS; THALASSEMIA; TREATMENT OUTCOME;

EID: 80055007995     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2011.08717.x     Document Type: Letter

References (10)

1. Alavian, S.M. & Tabatabaei, S.V. (2010) Treatment of chronic hepatitis C in polytransfused thalassaemic patients: a meta-analysis. Journal of Viral Hepatitis, 17, 236-244.
2. Di Marco, V., Bronte, F.; Sicily Group for the Study of Thalassemia, Capra, M., Gerardi., C., Maggio, A., Malizia, R. & Rizzo, M. (2007) HCV clearance among hemophiliacs and beta-thalassemics. Gastroenterolog, 132, 1634.
3. Di Marco, V., Capra, M., Angelucci, E., Borgna-Pignatti, C., Telfer, P., Harmatz, P., Kattamis, A., Prossamariti, L., Filosa, A., Rund, D., Gamberini, M.R., Cianciulli, P., De Montalembert, M., Gagliardotto, F., Foster, G., Grangè, J.D., Cassarà, F., Iacono, A., Cappellini, M.D., Brittenham, G.M., Prati, D., Pietrangelo, A., Craxì, A. & Maggio, A. (2010) Management of chronic viral hepatitis in patients with thalassemia: recommendations from an international panel. Blood, 21, 116.
4. Mancosu, M.G., Galanello, R., Ambu, R., De Virgiliis, S., Giagu, N., Cao, A. & Faa, G. (2000) Quadro istologico dell'epatopatia nella talassemia intermedia. Pathologica, 92, 241-248.
5. Origa, R., Galanello, R., Ganz, T., Giagu, N., Maccioni, L., Faa, G. & Nemeth, E. (2007) Liver iron concentrations and urinary hepcidin in b-thalassaemia. Haematologica, 92, 583-588.
6. Pagliano, P., Costantini, S., Gradoni, L., Faella, F.S., Spasiano, A., Mascarella, G., Prossomariti, L., Fusco, U. & Ricchi, P. (2008) Distinguishing visceral leishmaniasis from intolerance to pegylated interferon-alpha in a thalassemic splenectomized patient treated for chronic hepatitis C. American Journal of Tropical Medicine and Hygiene, 79, 9-11.
7. Prati, D., Zanella, A., Farma, E., De Mattei, C., Bosoni, P., Zappa, M., Picone, A., Mozzi, F., Rebulla, P., Cappellini, M.D., Allain, J.P. & Sirchia, G. (1998) A multicenter prospective study on the risk of acquiring liver disease in anti-hepatitis C virus negative patients affected from homozygous beta-thalassemia. Blood, 1, 92.
8. Ricchi, P., Ammirabile, M., Costantini, S., Cinque, P., Lanza, A.G., Spasiano, A., Di Matola, T., Di Costanzo, G., Pagano, L. & Prossomariti, L. (2010) The impact of previous or concomitant IFN therapy on deferiprone-induced agranulocytosis and neutropenia: a retrospective study. Expert Opinion on Drug Safety, 9, 875-881.
9. Tanner, M.A., Galanello, R., Dessi, C., Westwood, M.A., Smith Dore, F., Bonfigli, S., Pardini, S. & Longinotti, M. (1995) Serum interleukin-8 levels in thalassemia intermedia. Haematologica, 80, 431-433.
10. Wiener, E., Wanachiwanawin, W., Chinprasertsuk, S., Siripanyaphinyo, U., Mawas, F., Fucharoen, S. & Wickramasinghe, S.N. (1996) Increased serum levels of macrophage colony-stimulating factor (M-CSF) in alpha- and beta-thalassaemia syndromes: correlation with anaemia and monocyte activation. European Journal of Haematology, 57, 364-369.